DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Identifieur interne : 003984 ( PubMed/Corpus ); précédent : 003983; suivant : 003985DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Auteurs :Source :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2002.
English descriptors
- KwdEn :
- Benzophenones (pharmacology), Benzophenones (therapeutic use), Bromocriptine (pharmacology), Bromocriptine (therapeutic use), Dopamine Agonists (pharmacology), Dopamine Agonists (therapeutic use), Drug Therapy, Combination, Enzyme Inhibitors (pharmacology), Enzyme Inhibitors (therapeutic use), Ergolines (pharmacology), Ergolines (therapeutic use), Ergot Alkaloids (pharmacology), Ergot Alkaloids (therapeutic use), Humans, Levodopa (therapeutic use), Lisuride (pharmacology), Lisuride (therapeutic use), Nitrophenols, Parkinson Disease (drug therapy), Pergolide (pharmacology), Pergolide (therapeutic use), Randomized Controlled Trials as Topic.
- MESH :
- chemical , pharmacology : Benzophenones, Bromocriptine, Dopamine Agonists, Enzyme Inhibitors, Ergolines, Ergot Alkaloids, Lisuride, Pergolide.
- chemical , therapeutic use : Benzophenones, Bromocriptine, Dopamine Agonists, Enzyme Inhibitors, Ergolines, Ergot Alkaloids, Levodopa, Lisuride, Pergolide.
- drug therapy : Parkinson Disease.
- Drug Therapy, Combination, Humans, Nitrophenols, Randomized Controlled Trials as Topic.
DOI: 10.1002/mds.5562
PubMed: 12211141
Links to Exploration step
pubmed:12211141Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12211141</idno>
<idno type="pmid">12211141</idno>
<idno type="doi">10.1002/mds.5562</idno>
<idno type="wicri:Area/PubMed/Corpus">003984</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.</title>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Benzophenones (pharmacology)</term>
<term>Benzophenones (therapeutic use)</term>
<term>Bromocriptine (pharmacology)</term>
<term>Bromocriptine (therapeutic use)</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Enzyme Inhibitors (pharmacology)</term>
<term>Enzyme Inhibitors (therapeutic use)</term>
<term>Ergolines (pharmacology)</term>
<term>Ergolines (therapeutic use)</term>
<term>Ergot Alkaloids (pharmacology)</term>
<term>Ergot Alkaloids (therapeutic use)</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Lisuride (pharmacology)</term>
<term>Lisuride (therapeutic use)</term>
<term>Nitrophenols</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Pergolide (pharmacology)</term>
<term>Pergolide (therapeutic use)</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Benzophenones</term>
<term>Bromocriptine</term>
<term>Dopamine Agonists</term>
<term>Enzyme Inhibitors</term>
<term>Ergolines</term>
<term>Ergot Alkaloids</term>
<term>Lisuride</term>
<term>Pergolide</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Benzophenones</term>
<term>Bromocriptine</term>
<term>Dopamine Agonists</term>
<term>Enzyme Inhibitors</term>
<term>Ergolines</term>
<term>Ergot Alkaloids</term>
<term>Levodopa</term>
<term>Lisuride</term>
<term>Pergolide</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Nitrophenols</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">12211141</PMID>
<DateCreated><Year>2002</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2002</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>17 Suppl 4</Volume>
<PubDate><Year>2002</Year>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>S53-67</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001577">Benzophenones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004873">Ergolines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004876">Ergot Alkaloids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009596">Nitrophenols</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>24MJ822NZ9</RegistryNumber>
<NameOfSubstance UI="D010479">Pergolide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3A64E3G5ZO</RegistryNumber>
<NameOfSubstance UI="D001971">Bromocriptine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>CIF6334OLY</RegistryNumber>
<NameOfSubstance UI="C066340">tolcapone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>E0QN3D755O</RegistryNumber>
<NameOfSubstance UI="D008090">Lisuride</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>LL60K9J05T</RegistryNumber>
<NameOfSubstance UI="C047047">cabergoline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D001577">Benzophenones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001971">Bromocriptine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018491">Dopamine Agonists</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004791">Enzyme Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004873">Ergolines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004876">Ergot Alkaloids</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008090">Lisuride</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009596">Nitrophenols</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010479">Pergolide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016032">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>48</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year>
<Month>9</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2002</Year>
<Month>11</Month>
<Day>26</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2002</Year>
<Month>9</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12211141</ArticleId>
<ArticleId IdType="doi">10.1002/mds.5562</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003984 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003984 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:12211141 |texte= DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:12211141" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |